It’s widely known that weight regain is likely after discontinuing medication. But it’s the reversal of cardiovascular risk ...
ST. LOUIS, March 31, 2026 /PRNewswire/ -- A new research study from the American College of Lifestyle Medicine provides real-world evidence that deprescribing glucose--lowering medications is both ...
Eye doctors say GLP-1 drugs for diabetes and weight loss may pose rare vision risks, recommending regular checkups.
Emerging diabetes therapies are transforming MASLD treatment by addressing both metabolic dysfunction and liver disease, with new approvals and a growing pipeline signaling a shift in care. A rapidly ...
A new research study provides real-world evidence that deprescribing glucose‑lowering medications is both feasible and safe ...
A research team at Kumamoto University has developed an innovative method that uses a cyclic peptide to help insulin pass ...
Novo Nordisk India revises pricing to make vital therapies more affordable for patients managing diabetes and obesity ...
The Indian government has issued a strong warning against the misuse of glucagon-like peptide-1 receptor agonists (GLP-1) ...
Living with diabetes doesn’t have to mean accepting a lifetime of increasing medication doses and constant worry about blood sugar spikes. While traditional medical approaches focus heavily on ...
Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly ...
DALLAS, TX, UNITED STATES, March 31, 2026 /EINPresswire.com/ -- MedAdvisor, a leader in patient engagement, claims ...
When people with diabetes lose their health insurance, their condition doesn’t just stall. It gets worse, researchers at OHSU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results